In addition, 3-methylglutaconate and 3-methylglutarate, derived from leucine metabolism, showed 100 % sensitivity and specificity in distinguishing TMEM70-deficient patients from controls, highlighting their diagnostic potential for screening selected mitochondrial diseases [41]. The gene discussed is TMEM70; the disease is mitochondrial disease.